van Gils MJ - Search Results

1

Antibody responses against SARS-CoV-2 variants induced by four different SARS-CoV-2 vaccines in health care workers in the Netherlands: A prospective cohort study.

van Gils MJ, Lavell A, van der Straten K, Appelman B, Bontjer I, Poniman M, Burger JA, Oomen M, Bouhuijs JH, van Vught LA, Slim MA, Schinkel M, Wynberg E, van Willigen HDG, Grobben M, Tejjani K, van Rijswijk J, Snitselaar JL, Caniels TG; Amsterdam UMC COVID-19 S3/HCW study group; Vlaar APJ, Prins M, de Jong MD, de Bree GJ, Sikkens JJ, Bomers MK, Sanders RW. van Gils MJ, et al. Among authors: van vught la, van willigen hdg, van der straten k, van rijswijk j. PLoS Med. 2022 May 17;19(5):e1003991. doi: 10.1371/journal.pmed.1003991. eCollection 2022 May. PLoS Med. 2022. PMID: 35580156 Free PMC article.

2

Rapid escape from preserved cross-reactive neutralizing humoral immunity without loss of viral fitness in HIV-1-infected progressors and long-term nonprogressors.

van Gils MJ, Bunnik EM, Burger JA, Jacob Y, Schweighardt B, Wrin T, Schuitemaker H. van Gils MJ, et al. J Virol. 2010 Apr;84(7):3576-85. doi: 10.1128/JVI.02622-09. Epub 2010 Jan 13. J Virol. 2010. PMID: 20071586 Free PMC article.

3

Longer V1V2 region with increased number of potential N-linked glycosylation sites in the HIV-1 envelope glycoprotein protects against HIV-specific neutralizing antibodies.

van Gils MJ, Bunnik EM, Boeser-Nunnink BD, Burger JA, Terlouw-Klein M, Verwer N, Schuitemaker H. van Gils MJ, et al. J Virol. 2011 Jul;85(14):6986-95. doi: 10.1128/JVI.00268-11. Epub 2011 May 18. J Virol. 2011. PMID: 21593147 Free PMC article.

4

Evolution of human immunodeficiency virus type 1 in a patient with cross-reactive neutralizing activity in serum.

van Gils MJ, Edo-Matas D, Bowles EJ, Burger JA, Stewart-Jones GB, Schuitemaker H. van Gils MJ, et al. J Virol. 2011 Aug;85(16):8443-8. doi: 10.1128/JVI.05214-11. Epub 2011 Jun 8. J Virol. 2011. PMID: 21653664 Free PMC article.

5

Longitudinal analysis of early HIV-1-specific neutralizing activity in an elite neutralizer and in five patients who developed cross-reactive neutralizing activity.

Euler Z, van den Kerkhof TL, van Gils MJ, Burger JA, Edo-Matas D, Phung P, Wrin T, Schuitemaker H. Euler Z, et al. Among authors: van den kerkhof tl, van gils mj. J Virol. 2012 Feb;86(4):2045-55. doi: 10.1128/JVI.06091-11. Epub 2011 Dec 7. J Virol. 2012. PMID: 22156522 Free PMC article.

6

Broadly neutralizing antibodies against HIV-1: templates for a vaccine.

van Gils MJ, Sanders RW. van Gils MJ, et al. Virology. 2013 Jan 5;435(1):46-56. doi: 10.1016/j.virol.2012.10.004. Virology. 2013. PMID: 23217615 Free article. Review.

7

HIV-1 envelope glycoprotein resistance to monoclonal antibody 2G12 is subject-specific and context-dependent in macaques and humans.

Malherbe DC, Sanders RW, van Gils MJ, Park B, Gomes MM, Schuitemaker H, Barnett S, Haigwood NL. Malherbe DC, et al. Among authors: van gils mj. PLoS One. 2013 Sep 9;8(9):e75277. doi: 10.1371/journal.pone.0075277. eCollection 2013. PLoS One. 2013. PMID: 24040404 Free PMC article.

8

HIV-1 envelope glycoprotein signatures that correlate with the development of cross-reactive neutralizing activity.

van den Kerkhof TL, Feenstra KA, Euler Z, van Gils MJ, Rijsdijk LW, Boeser-Nunnink BD, Heringa J, Schuitemaker H, Sanders RW. van den Kerkhof TL, et al. Among authors: van gils mj. Retrovirology. 2013 Sep 23;10:102. doi: 10.1186/1742-4690-10-102. Retrovirology. 2013. PMID: 24059682 Free PMC article.

9

A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies.

Sanders RW, Derking R, Cupo A, Julien JP, Yasmeen A, de Val N, Kim HJ, Blattner C, de la Peña AT, Korzun J, Golabek M, de Los Reyes K, Ketas TJ, van Gils MJ, King CR, Wilson IA, Ward AB, Klasse PJ, Moore JP. Sanders RW, et al. Among authors: van gils mj. PLoS Pathog. 2013 Sep;9(9):e1003618. doi: 10.1371/journal.ppat.1003618. Epub 2013 Sep 19. PLoS Pathog. 2013. PMID: 24068931 Free PMC article.

10

Early development of broadly reactive HIV-1 neutralizing activity in elite neutralizers.

van den Kerkhof TL, Euler Z, van Gils MJ, Boeser-Nunnink BD, Schuitemaker H, Sanders RW. van den Kerkhof TL, et al. Among authors: van gils mj. AIDS. 2014 May 15;28(8):1237-40. doi: 10.1097/QAD.0000000000000228. AIDS. 2014. PMID: 24556870

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

217 results

Search Page

Filters